Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 4Unknown 2Terminated 1

Sponsor Class

OTHER 2FED 2

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Skin Neoplasms 1Prostate Cancer Prevention 1Multiple Endocrine Neoplasia Type 1 1Healthy Volunteers 1Dermatitis, Contact 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Gelatin × Clear all
NCT01265953 2019-05-01

PBroC

Portland VA Medical Center

Phase NA Completed
98 enrolled 10 charts
Genitourinary

Prostate Cancer Prevention

NCT01032343 2013-08-22

An Immunonutritional Approach to the Prevention of Skin Cancer

University of Manchester

Phase NA Completed
90 enrolled
Dermatologic

Dermatitis, Contact, Skin Neoplasms

NCT01526759 2012-03-12

FLiTS

Wageningen University

Phase NA Completed
35 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT01293617 2011-07-18

Blackberry Intake and Biomarkers of Cancer Risk

USDA Beltsville Human Nutrition Research Center

Phase NA Completed
52 enrolled

Healthy Volunteers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡